DIPG NTCC?人彌漫性真性腦橋神經(jīng)膠質(zhì)瘤細(xì)胞株Diffuse intrinsic pontine glioma cells-BioVector NTCC Inc.
- 價(jià) 格:¥98965
- 貨 號:NTCC?-DIPG
- 產(chǎn) 地:北京
- BioVector NTCC典型培養(yǎng)物保藏中心
- 聯(lián)系人:Dr.Xu, Biovector NTCC Inc.
電話:400-800-2947 工作QQ:1843439339 (微信同號)
郵件:Biovector@163.com
手機(jī):18901268599
地址:北京
- 已注冊
DIPG NTCC?人彌漫性真性腦橋神經(jīng)膠質(zhì)瘤細(xì)胞株Diffuse intrinsic pontine glioma cells-BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心
- CharacteristicsDIPG cells are typically small and monomorphic, but can also be large and pleomorphic. They usually have an astrocytic morphology, but can also have an oligodendroglial morphology.
- LocationDIPG tumors infiltrate the grey and white matter structures of the brain.
- GrowthDIPG tumors grow quickly and spread to nearby tissue and other parts of the brain stem.
- TreatmentRadiation therapy can shrink the tumor and reduce pressure on the brainstem, which can improve a child's condition for a few months. Other treatments include bromodomain and extra-terminal domain (BET) inhibitors and histone deacetylase (HDAC) inhibitors.
- PrognosisDIPG is a high-grade glioma that is considered incurable and has a poor prognosis. It is the leading cause of pediatric cancer-related death.
DIPG is rare in adults, but primarily affects children between the ages of 5 and 10 years. In the United States, about 300 children are diagnosed with DIPG each year.
Cell pictures:
BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心
www.biovector.net
您正在向 biovector.net 發(fā)送關(guān)于產(chǎn)品 DIPG NTCC?人彌漫性真性腦橋神經(jīng)膠質(zhì)瘤細(xì)胞株Diffuse intrinsic pontine glioma cells-BioVector NTCC Inc. 的詢問
- 公告/新聞